Selecta Biosciences (SELB) Tops Q2 EPS by 16c

Selecta Biosciences (NASDAQ: SELB) reported Q2 EPS of $0.04, $0.16 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $19.7 million versus the consensus estimate of $6.24 million.

For earnings history and earnings-related data on Selecta Biosciences (SELB) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Hitachi Ltd. (HIT) Misses Q2 EPS by 7c
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance